Berkshire Asset Management LLC Abb Vie Inc. Transaction History

Berkshire Asset Management LLC

$2.09 Billion
Q3 2024

A detailed history of Berkshire Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Berkshire Asset Management LLC holds 405,714 shares of ABBV stock, worth $73 Million. This represents 3.84% of its overall portfolio holdings.

Number of Shares

405,714

Previous 405,714 -0.0%

Holding current value

$73 Million

Previous $69.6 Million 15.13%

% of portfolio

3.84%

Previous 3.47%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $62.8 Million - $73.3 Million	405,714 New	405,714 $69.6 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $548,022 - $624,420	-3,429 Reduced 0.88%	388,310 $70.7 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $59,030 - $66,482	-429 Reduced 0.11%	391,739 $60.7 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $376,990 - $436,422	-2,822 Reduced 0.71%	392,168 $58.5 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $1.07 Million - $1.34 Million	8,101 Added 2.09%	394,990 $53.2 Million
Q1 2023 Jun 06, 2023	SELL	$144.61 - $166.54 $350,968 - $404,192	-2,427 Reduced 0.62%	386,889 $61.7 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $359,606 - $431,262	2,600 Added 0.67%	389,316 $63 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $685,947 - $786,736	-5,111 Reduced 1.3%	386,716 $51.9 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $948,614 - $1.21 Million	6,893 Added 1.79%	391,827 $60 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $491,229 - $609,477	3,722 Added 0.98%	384,934 $62.4 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $210,025 - $265,743	-1,955 Reduced 0.51%	381,212 $51.6 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $887,695 - $1.01 Million	8,343 Added 2.23%	383,167 $41.3 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $1.63 Million - $1.82 Million	15,501 Added 4.31%	374,824 $42.2 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $1.38 Million - $1.52 Million	-13,484 Reduced 3.62%	359,323 $38.9 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $2.63 Million - $3.55 Million	32,702 Added 9.62%	372,807 $39.9 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $2.22 Million - $2.61 Million	-25,853 Reduced 7.06%	340,105 $29.8 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $881,393 - $1.18 Million	12,013 Added 3.39%	365,958 $35.9 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $535,221 - $811,461	8,298 Added 2.4%	353,945 $27 Million
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $579,420 - $724,978	-8,033 Reduced 2.27%	345,647 $30.6 Million
Q3 2019 Oct 07, 2019	SELL	$62.98 - $75.72 $1.08 Million - $1.3 Million	-17,191 Reduced 4.64%	353,680 $26.8 Million
Q2 2019 Jul 29, 2019	BUY	$65.7 - $83.98 $1.56 Million - $1.99 Million	23,732 Added 6.84%	370,871 $27 Million
Q1 2019 Apr 16, 2019	BUY	$77.14 - $90.79 $29,698 - $34,954	385 Added 0.11%	347,139 $28 Million
Q4 2018 Jan 24, 2019	SELL	$77.85 - $96.01 $22,732 - $28,034	-292 Reduced 0.08%	346,754 $32 Million
Q3 2018 Oct 12, 2018	BUY	$88.91 - $98.84 $1.4 Million - $1.56 Million	15,748 Added 4.75%	347,046 $32.8 Million
Q2 2018 Jul 17, 2018	BUY	$89.78 - $106.23 $284,153 - $336,217	3,165 Added 0.96%	331,298 $30.7 Million
Q1 2018 May 01, 2018	BUY	$92.01 - $123.21 $274,465 - $367,535	2,983 Added 0.92%	328,133 $31.1 Million
Q4 2017 Jan 17, 2018	BUY	$89.56 - $98.21 $2.34 Million - $2.57 Million	26,126 Added 8.74%	325,150 $31.4 Million
Q3 2017 Oct 30, 2017	BUY	$69.85 - $89.22 $20.9 Million - $26.7 Million	299,024	299,024 $26.6 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Asset Management LLC with notifications on news.

Account

Berkshire Asset Management LLC Abb Vie Inc. Transaction History